However, adenomyosis-derived organoids demonstrated notable differences compared to healthy endometrial organoids, including overexpression of transforming growth factor beta 2 ( TGF2) and SMAD family member 3 ( SMAD3 )
Drawing on animal studies, the label estimates that an intravenous dose up to 30 mL of the 0.9% solution may be safely given to an adult without toxic effects, while an estimated 9 mL given to a 6 kg infant or neonate is potentially capable of producing blood pressure changes
[3] No human pharmacokinetic dataset exists
Ethics declarations Competing interests The authors declare no competing interests Additional information Publishers note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
YL: Conceptualization, Funding acquisition, Writing review and editing
Other Ingredients: Diluent (MCC), Methyl Paraben Sodium, Propyl Paraben Sodium, Sodium Starch Glycolate, Dicalcium Phosphate, Magnesium Stearate, Isopropyl Alcohol, Binding Agent (PVP), Food Additive (INS E228, 228, 321, 338, E381), Colour (PHS 7101 & PH017 1-6)
![Literature Review] Structural Biophysics-Guided Computational Design of Semaglutide Analogues to Enhance GLP-1R Activation](https://moonlight-paper-snapshot.s3.ap-northeast-2.amazonaws.com/arxiv/structural-biophysics-guided-computational-design-of-semaglutide-analogues-to-enhance-glp-1r-activation-1.png)
